Press Release

SOURCE: eResearchTechnology, Inc.

eResearchTechnology to Present at the UBS Global Life Sciences Conference 2007 on September 27th

PHILADELPHIA, Sept. 20 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading provider of centralized electrocardiographic (ECG) collection and interpretation services, announced today that Dr. Michael J. McKelvey, the Company's President and Chief Executive Officer, and Richard Baron, the Company's Chief Financial Officer, are scheduled to present at the UBS Global Life Sciences Conference at 8:30 a.m. Eastern on September 27, 2007 at the Grand Hyatt New York in New York City.

Interested parties may access a live audio webcast of the presentation by visiting the Company's corporate website at http://www.ert.com or at http://www.ibb.ubs.com. The webcast will be available via replay for 30 days.

About UBS

In wealth management, UBS's services are designed for high net worth and affluent individuals around the world, whether investing internationally or in their home country. UBS provides them with tailored, unbiased advice and investment services -- ranging from asset management to estate planning and from corporate finance to art banking. As an asset manager, UBS offers innovative investment management solutions in nearly every asset class to private, institutional and corporate clients, and through financial intermediaries. UBS investment capabilities comprise traditional assets (for instance equities, fixed income and asset allocation), alternative and quantitative investments (multimanager funds, funds of hedge funds, hedge funds) and real estate. In the investment banking and securities businesses, UBS provides securities products and research (in the areas of equities, fixed income, rates, foreign exchange, energy and metals) as well as advice and access to the world's capital markets to corporate, institutional, intermediary and alternative asset management clients. UBS's Swiss retail and corporate banking business provides a complete set of banking and securities services for domestic individual and corporate clients.

About eResearchTechnology:

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Forward-looking Statements:

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2007 financial guidance, involve a number of risks and uncertainties such as the company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Report on Form 10-K and 10Q filed with the Securities and Exchange Commission. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

    Contact:
    Richard Baron                       Brett Maas
    eResearchTechnology, Inc.           Hayden Communications
    215-282-5566                        646-536-7331